Market Mover | OB Holdings Surged Over 4% on Its IPO Debut

Significantly, OB Holdings Bhd published its financial report for the first quarter of FY25 on 23rd October. The report revealed that the company's revenue for the quarter reached RM12.02 million, with a net profit of RM1.44 million and earnings per share (EPS) of 2.69 sen.

OB Holdings Berhad, a Malaysian investment holding company established in 2023, is a major player in fortified food and beverage (F&B) and dietary supplements. It operates through subsidiaries Orient Biotech, Orient Laboratories, and Bonlife, offering comprehensive manufacturing services from product development to distribution for both third-party brands and its own house brands. OB Holdings has a strong distribution network, reaching consumers via e-commerce and through distributors/retailers. The company is committed to quality, holding certifications like ISO 9001:2015, FDA, HACCP, and NASAA Certified Organic, with 10 of its 12 products achieving NASAA organic status.

The funds raised, totaling RM28.8 million, will be allocated towards several key areas: business expansion, marketing and advertisement, working capital and listing expenses.